Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma
- PMID: 1947211
- DOI: 10.1016/0167-8140(91)90067-q
Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma
Abstract
This paper describes the results of radiotherapy in early stage orbital non-Hodgkin's lymphoma. From 1970 to 1985, 33 orbital localizations in 30 patients were treated. The total dose applied ranged from 21 to 57 Gy (2 Gy per fraction), two-thirds of all patients received a dose of 40 Gy. The complete-response rate was 94% and the 10 years actuarial survival was 90%; no significant difference in survival was observed between patients with low grade or intermediate grade lymphoma. No local recurrence was detected during follow up and 20% of the patients developed generalized disease. Two optic nerve neuropathies and three retinopathies were observed in five patients, four of these occurred at a dose level of less than 43 Gy. Keratitis occurred in 58% of the patients treated, a sicca syndrome in 30% and cataract of different grades in 58% of the patients treated. Although local control was excellent, severe complications were observed in 13% of the patients who received a dose of less than 43 Gy.
Similar articles
-
Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy.Ophthalmologica. 2007;221(5):348-52. doi: 10.1159/000104766. Ophthalmologica. 2007. PMID: 17728558
-
Orbital lymphoma: radiotherapy outcome and complications.Radiother Oncol. 2001 May;59(2):139-44. doi: 10.1016/s0167-8140(00)00328-5. Radiother Oncol. 2001. PMID: 11325441
-
Local control and complications after radiation therapy for primary orbital lymphoma: a case for low-dose treatment.Int J Radiat Oncol Biol Phys. 1991 Apr;20(4):791-6. doi: 10.1016/0360-3016(91)90025-y. Int J Radiat Oncol Biol Phys. 1991. PMID: 2004956
-
Curative radiotherapy for primary orbital lymphoma.Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):818-23. doi: 10.1016/s0360-3016(02)02966-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 12377334 Review.
-
Orbital lymphoma: role of radiation.Indian J Ophthalmol. 2009 Mar-Apr;57(2):91-7. doi: 10.4103/0301-4738.44516. Indian J Ophthalmol. 2009. PMID: 19237780 Free PMC article. Review.
Cited by
-
Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis.Radiat Oncol. 2009 Dec 7;4:60. doi: 10.1186/1748-717X-4-60. Radiat Oncol. 2009. PMID: 19968864 Free PMC article.
-
Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma.Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):930-5. doi: 10.1016/j.ijrobp.2013.04.035. Epub 2013 May 29. Int J Radiat Oncol Biol Phys. 2013. PMID: 23726002 Free PMC article.
-
Pharmacological prevention of radiation-induced dry eye-an experimental study in a rabbit model.Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1347-55. doi: 10.1007/s00417-007-0548-y. Epub 2007 Feb 21. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17318564
-
Electron therapy for orbital and periorbital lesions using customized lead eye shields.Ophthalmologica. 2009;223(2):96-101. doi: 10.1159/000176190. Epub 2008 Nov 26. Ophthalmologica. 2009. PMID: 19033716 Free PMC article.
-
Ocular surface changes in patients who have undergone head and neck radiation therapy.Indian J Ophthalmol. 2024 Jul 1;72(Suppl 4):S669-S675. doi: 10.4103/IJO.IJO_1080_23. Epub 2024 Feb 23. Indian J Ophthalmol. 2024. PMID: 38389244 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
